Stem Cell Technology
Tags: HEMATOPOIETIC stem cells -- Transplantation; BONE marrow cells -- Transplantation; TRANSPLANTATION immunology
Related Articles
- Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia. Lodewyck, T; Oudshoorn, M; van der Holt, B; Petersen, E; Spierings, E; von dem Borne, P A; Schattenberg, A; Allebes, W; Groenendijk-Sijnke, M; Duinhouwer, L; Willemze, R; Lowenberg, B; Verdonck, L F; Meijer, E; Cornelissen, J J // Leukemia (08876924);Oct2011, Vol. 25 Issue 10, p1548
Many parameters predict for outcome after unrelated donor (URD) allogeneic hematopoietic stem cell transplantation (alloSCT). High-resolution HLA-matching significantly impacts outcome and also the European Group of Blood and Marrow Transplantation (EBMT) risk score, based on patient age,...
- Control of Acute Myeloid Leukemia Relapse--Dance between KIRs and HLA. Miller, Jeffrey S.; Blazar, Bruce R. // New England Journal of Medicine;8/30/2012, Vol. 367 Issue 9, p866
The article comments on a study published in this issue of the journal which examined the interaction between killer-cell immunoglobulin-like receptor (KIR) genes and human leucocyte antigen (HLA) in hematopoietic stem-cell transplantation (HSCT). It cites some unanswered question on the...
- Indoleamine 2,3-Dioxygenase in Human Hematopoietic Stem Cell Transplantation. J�rgens, Birgit; Raberger, Julia; Fuchs, Dietmar; Heitger, Andreas // International Journal of Tryptophan Research;2010, Issue 3, p77
In recent years tryptophan metabolism and its rate limiting enzyme indoleamine 2,3-dioxygenase (IDO) have attracted increasing attention for their potential to modulate immune responses including the regulation of transplantation tolerance. The focus of this review is to discuss some features of...
- Lack of effect of donor�recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. Klumpp, T. R.; Herman, J. H.; Ulicny, J.; Emmons, R. V. B.; Martin, M. E.; Mangan, K. F. // Bone Marrow Transplantation;Nov2006, Vol. 38 Issue 9, p615
Several recently published studies have suggested that patients who undergo ABO mismatched hematopoietic stem cell transplantation may be at increased risk for relapse, graft-versus-host disease, transplant-related mortality, and/or all-cause mortality. To investigate this issue further, we...
- 11: Kidney-Transplant Patients Survive With-out Drugs. Bakalar, Nicholas // Discover;Jan2009, Vol. 30 Issue 1, p32
The article, one in a series of the top science stories of 2008, focuses on a procedure for organ transplantation begun at Massachusetts General Hospital in Boston that eliminates the need for long-term drugs. Patients with end-stage renal disease who were given kidney transplants along with...
- High Morbidity Burden Borne Years Later by Survivors of Transplant. Helwick, Caroline // American Health & Drug Benefits;Feb Special Issue 2012, Vol. 5, p22
The article discusses research on hematopoietic cell transplant which was reported at a 2012 press conference by Stephanie J. Lee of the University of Washington School of Medicine in Seattle, Washington. The research found that while the transplants may cure many hematologic malignancies...
- Regionally limited or rare infections: prevention after hematopoietic cell transplantation. Gea-Banacloche, J; Masur, H; da Cunha, C Arns; Chiller, T; Kirchhoff, L V; Shaw, P; Tomblyn, M; Cordonnier, C // Bone Marrow Transplantation;Apr2010, Vol. 45 Issue 4, p806
A correction to the article "Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective" that was published in 2009 issue is presented.
- Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors. Mazzi, B.; Clerici, T. D.; Zanussi, M.; Lupo Stanghellini, M. T.; Vago, L.; Sironi, E.; Peccatori, J.; Bernardi, M.; Carrera, P.; Palini, A.; Rossini, S.; Bordignon, C.; Bonini, C.; Ferrari, M.; Ciceri, F.; Fleischhauer, K. // Leukemia (08876924);Nov2008, Vol. 22 Issue 11, p2119
A letter to the editor is presented in response to the article "Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse" that was published in a previous issue.
- Lupus: tinkering with haematopoietic stem cells. Marmont, A. // Lupus;Nov2001, Vol. 10 Issue 11, p769
Examines haematopoietic stem cell (HSC) transplantation which might be, or become, a powerful treatment for severe, relapsing/refractory cases of systemic lupus erythematosus. One of the most important findings in allogeneic HSC; Major improvements in the safety of allogeneic HSC...
